Document is current

The potential use of recombinant immunotoxin and BCL-2 inhibitors for leukemic stem cell elimination

Crossref DOI link: https://doi.org/10.30574/wjarr.2023.20.3.2571

Published Online: 2023-12-30

Update policy: https://doi.org/10.30574/wjarr.ourcrossmarkpolicy